Advanced Science,
Journal Year:
2024,
Volume and Issue:
unknown
Published: July 19, 2024
Abstract
Furin
primarily
localizes
to
the
trans
‐Golgi
network
(TGN),
where
it
cleaves
and
activates
a
broad
range
of
immature
proproteins
that
play
critical
roles
in
cellular
homeostasis,
disease
progression,
infection.
is
retrieved
from
endosomes
TGN
after
being
phosphorylated,
but
still
unclear
how
furin
exits
initiate
post‐Golgi
trafficking
its
activity
regulated
TGN.
Here
three
membrane‐associated
RING‐CH
finger
(MARCHF)
proteins
(2,
8,
9)
are
identified
as
E3
ubiquitin
ligases,
which
catalyze
K33‐polyubiquitination.
Polyubiquitination
prevents
maturation
by
blocking
ectodomain
cleavage
inside
cells
promotes
egress
shedding.
Further
ubiquitin‐specific
protease
32
(USP32)
deubiquitinase
counteracts
MARCHF
inhibitory
on
furin.
Thus,
an
interplay
between
polyubiquitination
phosphorylation.
required
for
anterograde
transport
inhibits
proprotein
convertase
activity,
phosphorylation
retrograde
produce
fully
active
cells.
Journal of Virology,
Journal Year:
2023,
Volume and Issue:
97(10)
Published: Sept. 29, 2023
Emerging
vaccine-breakthrough
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
variants
highlight
an
urgent
need
for
novel
antiviral
therapies.
Understanding
the
pathogenesis
of
coronaviruses
is
critical
developing
drugs.
Here,
we
demonstrate
that
SARS-CoV-2
N
protein
suppresses
interferon
(IFN)
responses
by
reducing
early
growth
response
gene-1
(EGR1)
expression.
The
overexpression
EGR1
inhibits
replication
promoting
IFN-regulated
expression,
which
interacts
with
and
degrades
via
E3
ubiquitin
ligase
MARCH8
cargo
receptor
NDP52.
mutants
without
activity
are
no
longer
able
to
degrade
proteins,
indicating
proteins
dependent
on
its
activity.
This
study
found
a
immune
evasion
mechanism
utilized
protein,
helpful
understanding
guiding
design
new
prevention
strategies
against
emerging
coronaviruses.
ACS Infectious Diseases,
Journal Year:
2024,
Volume and Issue:
10(3), P. 879 - 889
Published: Feb. 22, 2024
The
highly
infectious
coronavirus
SARS-CoV-2
relies
on
the
viral
main
protease
(Mpro,
also
known
as
3CLpro
or
Nsp5)
to
proteolytically
process
polyproteins
encoded
by
genome
for
release
of
functional
units
in
host
cells
initiate
replication.
Mpro
interacts
with
proteins
innate
immune
pathways,
such
IRF3
and
STAT1,
suppress
their
activities
facilitate
virus
survival
proliferation.
To
identify
mechanism
regulating
Mpro,
we
screened
various
classes
E3
ubiquitin
ligases
found
that
Parkin
RING-between-RING
family
can
induce
ubiquitination
degradation
cell.
Furthermore,
when
undergo
mitophagy,
PINK1
kinase
activates
enhances
Mpro.
We
elevated
expression
significantly
decreased
replication
virus.
Interestingly,
infection
downregulates
mouse
lung
tissues
compared
healthy
controls.
These
results
suggest
an
antiviral
role
a
ligase
targeting
potential
exploiting
virus–host
interaction
mediated
treat
infection.
PLoS Pathogens,
Journal Year:
2023,
Volume and Issue:
19(9), P. e1011619 - e1011619
Published: Sept. 14, 2023
The
host
cell
membrane-associated
RING-CH
8
protein
(MARCH8),
a
member
of
the
E3
ubiquitin
ligase
family,
regulates
intracellular
turnover
many
transmembrane
proteins
and
shows
potent
antiviral
activities.
Generally,
2
modes
are
performed
by
MARCH8.
On
one
hand,
MARCH8
catalyzes
viral
envelope
glycoproteins
(VEGs)
ubiquitination
thus
leads
to
their
degradation,
which
is
cytoplasmic
tail
(CT)-dependent
(CTD)
mode.
other
traps
VEGs
at
some
compartments
(such
as
trans-Golgi
network,
TGN)
but
without
inducing
tail-independent
(CTI)
mode,
hijacks
furin,
cellular
proprotein
convertase,
block
cleavage.
In
addition,
C-terminal
tyrosine-based
motif
(TBM)
222YxxL225
also
plays
key
role
in
its
CTI
effects.
contrast
potency,
occasionally
hijacked
viruses
bacteria
enhance
invasion,
indicating
duplex
pathogenic
infections.
This
review
summarizes
MARCH8's
roles
how
evade
restriction,
shedding
light
on
novel
therapeutic
avenues.
Antiviral Research,
Journal Year:
2023,
Volume and Issue:
221, P. 105790 - 105790
Published: Dec. 27, 2023
The
SARS-CoV-2
envelope
(E)
protein
is
highly
conserved
among
different
viral
variants
and
important
for
assembly
production.
Our
recent
study
found
that
the
E
ubiquitinated
degraded
by
E3
ligase
RNF5
through
proteasome
pathway.
However,
whether
ubiquitination
can
be
reversed
host
deubiquitinase
has
not
yet
been
determined.
Here,
we
identify
mass
spectrum
analysis
deubiquitinases
USP14
USP39
specifically
interact
with
E,
while
potently
reverses
polyubiquitination.
interacts
via
arginine-rich
motif
(AR)
deubiquitinates
polyubiquitination
inactive
ubiquitin-specific
protease
domain.
Therefore,
protects
from
RNF5-mediated
degradation,
resulting
in
enhancement
of
stability
E-induced
cytokine
storms.
Moreover,
loss-and-gain
assays
demonstrated
promotes
replication
various
strains
stabilizing
level
but
other
proteins.
findings
provide
useful
targets
development
novel
anti-SARS-CoV-2
strategies.
Journal of Medical Virology,
Journal Year:
2025,
Volume and Issue:
97(1)
Published: Jan. 1, 2025
ABSTRACT
Kaposi's
sarcoma‐associated
herpesvirus
(KSHV)
employs
diverse
mechanisms
to
subvert
host
immune
responses,
contributing
its
infection
and
pathogenicity.
As
an
evasion
strategy,
KSHV
encodes
the
Membrane‐Associated
RING‐CH
(MARCH)‐family
E3
ligases,
K3,
K5,
which
target
remove
several
regulators
from
cell
surface.
In
this
study,
we
investigate
impact
of
K3
K5
on
lymphotoxin
receptor
(LTβR)
ligands,
LTβ
LIGHT,
are
type
II
transmembrane
proteins
function
as
pivotal
mediators
during
virus
infection.
Upon
co‐expression
viral
MARCH
with
LTβR
showed
that
selectively
targeted
LTβ,
but
not
for
downregulation
surface
expression.
Specifically,
ligases
interacted
domain
LTβ.
Intriguingly,
immature
form
whereas
fully
mature
form.
Subsequent
biochemical
analyses
revealed
disrupted
initial
steps
N‐glycosylation
maturation
This
interference
resulted
in
sequestration
within
endoplasmic
reticulum,
impeding
trafficking
plasma
membrane.
Consequently,
K3‐mediated
expression
suppressed
downstream
signaling
pathway.
These
findings
uncover
a
novel
mechanism
by
ligase
inhibits
membrane
pathway
inflammatory
ligand
through
glycosylation
interference,
potentially
evading
LTβR‐mediated
antiviral
immunity.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: Jan. 23, 2025
Viral
infectious
diseases,
caused
by
numerous
viruses
including
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
influenza
A
virus
(IAV),
enterovirus
(EV),
human
immunodeficiency
(HIV),
hepatitis
B
(HBV),
and
papillomavirus
(HPV),
pose
a
continuous
threat
to
global
health.
As
obligate
parasites,
rely
on
host
cells
replicate,
have
developed
defense
mechanisms
counteract
viral
infection.
Host
restriction
factors
(HRFs)
are
critical
components
of
the
early
antiviral
response.
These
cellular
proteins
inhibit
replication
spread
impeding
essential
steps
in
life
cycle,
such
as
entry,
genome
transcription
replication,
protein
translation,
particle
assembly,
release.
This
review
summarizes
current
understanding
how
with
primary
focus
their
diverse
against
range
viruses,
SARS-CoV-2,
virus,
enteroviruses,
papillomavirus.
In
addition,
we
highlight
crucial
role
these
shaping
host-virus
interactions
discuss
potential
targets
for
drug
development.
mBio,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 12, 2025
ABSTRACT
Membrane-associated
RING-CH-type
finger
(MARCH)
proteins,
a
class
of
E3
ubiquitin
ligases,
have
been
reported
to
be
involved
in
the
infection
multiple
viruses
and
regulation
type
I
interferon
(IFN)
production.
However,
specific
role
mechanisms
by
which
MARCH
proteins
influence
Japanese
encephalitis
virus
(JEV)
remain
poorly
understood.
Here,
we
systematically
investigate
functional
relevance
JEV
replication
examining
effects
siRNA-mediated
knockdown
MARCHs
on
viral
infection.
We
identified
MARCH5
as
positive
regulator
replication.
The
knockout
dramatically
reduced
yields,
whereas
its
overexpression
significantly
enhanced
Mechanistically,
specifically
interacts
with
envelope
(E)
protein
promotes
K27-linked
polyubiquitination
at
lysine
(K)
residues
136
166.
This
ubiquitination
enhances
attachment
permissive
cells.
Substituting
these
arginine
(R)
attenuated
vitro
virulence
vivo
.
Furthermore,
upregulated
expression
MARCH5.
also
discovered
that
degrades
mitochondrial
antiviral-signaling
(MAVS)
through
ubiquitin-proteasome
pathway
catalyzing
K48-linked
ubiquitination,
thereby
inhibiting
IFN
production
JEV-infected
suppression
further
facilitates
In
conclusion,
findings
disclosed
novel
positively
regulating
revealed
an
important
mechanism
employed
regulate
innate
immune
response.
IMPORTANCE
is
leading
cause
many
countries
Asia
estimated
100,000
clinical
human
cases
causes
economic
loss
swine
industry.
Until
now,
there
no
clinically
approved
antiviral
for
treatment
Although
vaccination
prophylaxis
widely
regarded
most
effective
strategy
preventing
(JE),
incidence
JE
continues
rise.
Thus,
deeper
understanding
virus-host
interaction
will
enrich
our
knowledge
underlying
identify
targets
development
next-generation
live-attenuated
vaccines
therapies.
To
best
knowledge,
this
study
first
pro-viral
host
factor
elucidated
two
distinct
First,
E
mediates
K136
K166
facilitate
efficient
attachment.
double
mutations
K136R-K166R
mice.
Second,
induced
suppresses
RIG-I-like
receptor
(RLR)
signaling
benefit
downregulates
conjugating
polyubiquitin
K286
MAVS,
leads
MAVS
degradation
pathway.
summary,
provides
insights
into
played
identifies
sites
could
targeted
attenuation
therapeutics.
Autophagy,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 13, 2025
Ebola
virus
disease
(EVD)
caused
by
Zaire
Ebolavirus
(EBOV)
infection
is
a
major
threat
to
public
health
in
Africa
and
even
worldwide,
due
its
extremely
high
mortality
rate.
However,
there
are
still
no
effective
antiviral
therapies
that
can
completely
cure
EVD.
A
comprehensive
understanding
of
virus-host
interactions
would
be
beneficial
for
developing
new
agents.
Here,
we
showed
CXCR4-induced
macroautophagy/autophagy
was
internalized
endosomes
interacting
with
glycoprotein
(GP)
on
viral
particles
during
EBOV
infection;
this
promoted
the
attachment
entry,
which
reduced
CXCR4
antagonist
neutralizing
antibody.
We
also
found
increased
replication
downregulating
cytotoxic
GP
promote
fitness
instead
influencing
assembly
factory.
Mechanistically,
excessive
could
hijack
sorting
transporting
pathways
their
HGS,
one
key
components
ESCRT
machinery;
subsequently
carried
back
endoplasmic
reticulum
CXCR4,
where
E3
ubiquitin
ligase
RNF185
recruited
polyubiquitinate
K27-
K63-linked
manner.
Finally,
polyubiquitinated
degraded
lysosomes
via
reticulophagy
RETREG1
(reticulophagy
regulator
1),
an
ATG3-
ATG5-dependent
Our
findings
revealed
dual
roles
regulation
life
cycle,
either
acting
as
entry
factor
facilitate
or
targeting
reticulophagic
degradation,
providing
evidence
hijacked
host
vesicular
transportation
system
through
efficient
fitness.
Frontiers in Antibiotics,
Journal Year:
2025,
Volume and Issue:
4
Published: May 6, 2025
The
worldwide
increasing
frequency
and
severity
of
multidrug-resistant
gastrointestinal
(MDR-GI)
infections
not
only
raises
awareness
the
debilities
conventional
antibiotic
treatments
but
also
highlights
demand
for
alternative
interventions.
One
these
alternatives
is
probiotics,
harmless
bacteria
that
compete
with
pathogenic
species,
which
have
been
considered
beneficial
due
to
their
therapeutic
potential
since
they
strengthen
mucosal
barrier
modulate
host
immune
response.
Other
natural
compounds
(e.g.,
polyphenols,
flavonoids,
essential
oils)
present
diverse
antimicrobial
mechanisms,
are
promising
mitigate
resistant
pathogens.
Finally,
bacteriophages,
viruses
target
specific
bacteria,
constitute
a
precise
approach
in
MDR
lysed
or
disrupted
by
biofilms
formed
during
colonization
without
compromising
normal
gut
microbiome.
Therefore,
manuscript
provides
an
integrated
perspective
on
non-antibiotic
therapies
manage
MDR-GI
infections;
this
purpose,
it
covers
aspects
such
as
action
current
clinical
applications,
challenges
limit
broader
application
practice.
combining
approaches
personalizing
infection
adjusted
patients’
microbiome
profiles
discussed,
aiming
enhance
efficacy
reduce
resistance
risks.
importance
continued
research
development
optimize
debated,
addressing
need
surpass
regulatory
barriers
conducting
large-scale
trials
establish
safety
alternatives.
This
overview
knowledge
contributes
ongoing
efforts
develop
sustainable
strategies
combat
global
burden
resistance.